Sunday, 17 June 2007

Indonesia's AIDS epidemic among the fastest growing in Asia




JAKARTA (AP): Indonesia's AIDS epidemic is among the fastest growing
in Asia, especially among intravenous drug users and commercial sex
workers, and half of new infections have been found in the
easternmost Papua province, the World Health Organization said.

"Indonesia is facing a huge threat," Bjorn Melgaard, WHO's senior
health consultant, said Saturday after an independent review team
spent nearly two weeks surveying efforts to fight theAIDS virus in
several provinces across the sprawling archipelago.

The team found that the government has put in place good strategies
and intervention programs to handle the epidemic, but more needs to
be done on a local level to secure long-term funding to fight the
spread of HIV, the virus that causes AIDS, and to improve access to
condoms, testing and counseling.

Surveillance of sexually transmitted disease also needs to be stepped
up, the team found.

There were 2,873 new AIDS cases in Indonesia in 2006, a 140 percent
increase from 1,195 in 2004, with most cases found in intravenous
drug users and commercial sex workers, the team said.

Papua, the country's most remote province geographically and
politically, had by far the largest population of people living with
the AIDS virus, accounting for 20 times the national average- around
50 percent of the country's total number of cases.

"More than 2 percent of the population in Papua were infected with
HIV/AIDS," the report said, adding that health centers in the
province must work especially hard to strengthen programs to prevent
mothers from spreading the virus to their children.

WHO warned late last year that Indonesia showed a trend that its AIDS
epidemic was still not under control, compared to neighboring
Thailand and Cambodia, where rates of infection appear to
stabilizing.

"Its HIV/AIDS epidemic is among the fastest growing in Asia,"
Melgaard said.

HIV has infected an estimated 169,000 to 216,000 in the nation of 220
million. (***)

http://www.thejakartapost.com/detailtoplatest.asp?
fileid=20070218150244&irec=0

AIDS virus weakness detected



http://www.reuters.com/article/topNews/idUSN1438308620070214?src=021407_1823_ARTICLE_PROMO_also_on_reuters

Wed Feb 14, 2007 4:19PM EST

By Will Dunham

WASHINGTON (Reuters) - Scientists have captured an image of the AIDS virus in a biological handshake with the immune cells it attacks, and said on Wednesday they hope this can help lead to a better vaccine against the incurable disease.

They pinpointed a place on the outside of the human immunodeficiency virus that could be vulnerable to antibodies that could block it from infecting human cells.

U.S. National Institutes of Health researcher Peter Kwong said the study, published in the journal Nature, may reveal HIV's long-sought "site of vulnerability" that can be targeted with a vaccine aimed at preventing initial infection.

"Having that site and knowing that you can make antibodies against it means that a vaccine is possible," Kwong said in a telephone interview.

"It doesn't say we've gotten there. But it's taken it off the list from an impossible dream and converted it to something that is a (mere) technical barrier."

Experts agree that a vaccine is the only hope of stopping the pandemic of AIDS, which has killed more than 25 million people since it was first recognized in 1981. About 40 million people now live with HIV, with sub-Saharan Africa hardest hit.

But while dozens of potential vaccines are in development, only two AIDS vaccine candidates are in advanced human trials -- one made by Merck and Co. and another by Sanofi-Aventis SA.

Because the virus attacks immune system cells, it has been especially difficult to design a vaccine to fight it.

The team at the National Institute of Allergy and Infectious Diseases, part of the NIH, made atomic-level images of the virus.

They revealed the structure of a protein on the surface of HIV as it looks while the protein is bound to an infection-fighting antibody. They said this protein, called gp120, seems susceptible to attack by this antibody, which is called b12 and is capable of broadly neutralizing the virus.

An antibody is an immune system protein that helps seek and destroy invaders like viruses and bacteria.

CAUTIOUS HANDSHAKE

The researchers detailed the precise interaction as the virus tries to grab and infect cells sent to protect the body.

"The first contact is like a cautious handshake, which then becomes a hearty bear hug," said Dr. Gary Nabel, an NIH vaccine expert and a co-author of the research.

The virus uses the protein gp120 to gain entry into the CD4 T-cells it infects. But the researchers also found that the antibody b12 can block this process.

The virus mutates quickly and continuously to beat the immune system's efforts to target it. It also is cloaked in such a way that it stops antibodies from blocking the proteins that HIV uses to bind to a cell and infect it.

So this is a critical area of vulnerability, Nabel said. "This is certainly one of the best leads to come along in recent years," he said.

NIAID Director Dr. Anthony Fauci said the findings are of great importance, but much more work in animal and human studies is needed, and any vaccine is years away.

"I don't think there's any one particular thing that, in and of itself, is the show-stopper. But I don't think we could really make substantial, fundamentally scientifically based progress until we got this very important information," he said.

The World Medical Association Statement on HIV/AIDS and the Medical




Adopted by the WMA General Assembly, Pilanesberg, South Africa,
October 2006

Introduction

1. HIV/AIDS is a global pandemic that has created unprecedented challenges for physicians and health infrastructures. In addition to representing a staggering public health crisis, HIV/AIDS is also fundamentally a human rights issue. Many factors drive the spread of the disease, such as poverty, homelessness, illiteracy, prostitution, human trafficking, stigma, discrimination and gender-based inequality. Efforts to tackle the disease are constrained by the lack of human and financial resources available in health care systems. These social, economic, legal and human rights factors affect not only the public health dimension of HIV/AIDS but also individual physicians/health workers and patients, their decisions and relationships.

Discrimination

Unfair discrimination against HIV/AIDS patients by physicians must be eliminated completely from the practice of medicine.

  1. All persons infected or affected by HIV/AIDS are entitled toadequate prevention, support, treatment and care with compassion andrespect for human dignity.
  2. A physician may not ethically refuse to treat a patient whose condition is within his or her current realm of competence, solelybecause the patient is seropositive.
  3. National Medical Associations should work with governments, patient groups and relevant national and international organizations to ensure that national health policies clearly and explicitly prohibit discrimination against people infected with or affected by HIV/AIDS.

Appropriate / Competent Medical Care

  1. Patients with HIV/AIDS must be provided with competent and appropriate medical care at all stages of the disease.
  2. A physician who is not able to provide the care and services required by patients with HIV/AIDS should make an appropriate referral to those physicians or facilities that are equipped to provide such services. Unless or until the referral can be accomplished, the physician must care for the patient to the best of his or her ability.
  3. Physicians and other appropriate bodies should ensure that patients have accurate information regarding means of transmission of HIV/AIDS and strategies to protect themselves against infection. Proactive measures should be taken to ensure that all members of the population, and at-risk groups in particular, are educated to thiseffect.
  4. With reference to those patients who are found to be seropositive, physicians must be able to effectively counsel themregarding: (a) responsible behaviour to prevent the spread of the disease; (b) strategies for their own health protection; and (c) the necessity of alerting sexual and needle-sharing contacts, past and present, as well as other relevant contacts (such as medical and dental personnel) regarding their possible infection.
  5. Physicians must recognize that many people still believe HIV/AIDS to be an automatic and immediate death sentence and therefore will not seek testing. Physicians must ensure that patients have accurate information regarding the treatment options available to them.
  6. Patients should understand the potential of antiretroviral treatment (ART) to improve not only their medical condition but also the quality of their lives. Effective ART can greatly extend the period of time that patients are able to lead healthy productive lives, functioning socially and in the workplace and maintaining their independence. HIV/AIDS is increasingly looked upon as a manageable chronic condition.
  7. While strongly advocating ART as the best course of action for HIV/AIDS patients, physicians must also ensure that their patients are fully and accurately informed about all aspects of ART, including potential toxicity and side effects. Physicians must also counsel patients honestly about the possibility of failure of first line ART, and the subsequent options should failure occur. The importance of adhering to the regimens and thereby reducing the risk of failure should be emphasized. Physicians should be aware that misinformation regarding the negative aspects of ART has created resistance toward treatment by patients in some areas. Where misinformation is being spread about ART, physicians and medical associations must make it an immediate priority to publicly challenge the source of the misinformation and to work with the HIV/AIDS community to counteract the negative effects of the misinformation.
  8. Physicians should encourage the involvement of support networks to assist patients in adhering to ART regimens. With the patient's consent, counselling and training should be available to family members to assist them in providing family based care. Physicians must recognize families and other support networks as crucial partners in adherence strategies and, in many places, the only means to adequately expand the care system so that patients receive the required attention.
  9. Physicians must be aware of the discriminatory attitudes toward HIV/AIDS that are prevalent in society and local culture. Because physicians are the first, and sometimes the only, people who are informed of their patients' HIV status, physicians should be able to counsel them about their basic social and legal rights and responsibilities or should refer them to counsellors who specialize in the rights of persons living with HIV/AIDS.

Testing

  1. Mandatory testing for HIV must be required of: donated blood and blood fractions collected for donation or to be used in the manufacture of blood products; organs and other tissues intended for transplantation; and semen or ova collected for assisted reproduction procedures.
  2. Mandatory HIV testing of an individual against his or her will is a violation of medical ethics and human rights. Exceptions to this rule may be made only in the most extreme cases and should be subject to review by an ethics panel or to judicial review.
  3. Physicians must clearly explain the purpose of an HIV test, the reasons it is recommended and the implications of a positive test result. Before a test is administered, the physician should have an action plan in place in case of a positive test result. Informed consent must be obtained from the patient prior to testing.
  4. While certain groups are labelled "high risk", anyone who has had unprotected sex should be considered at some risk. Physicians must become increasingly proactive about recommending testing to patients, based on a mutual understanding of the level of risk and the potential to benefit from testing.Pregnant women should routinely be offered testing.
  5. Counselling and voluntary anonymous testing for HIV should be available to all persons who request it, along with adequate post-testing support mechanisms.

Protection from HIV in the Health Care Environment

Physicians and all health care workers have the right to a safe work environment. Especially in developing countries, the problem of occupational exposure to HIV has contributed to high attrition rates of the health labour force. In some cases, employees become infected with HIV, and in other cases fear of infection causes health care workers to leave their jobs voluntarily. Fear of infection among health workers can also lead to refusal to treat HIV/AIDS patients.
Likewise, patients have the right to be protected to the greatest degree possible from transmission of HIV from health professionals and in health care institutions.

  1. Proper infection control procedures and universal precautions consistent with the most current national or international standards, as appropriate, should be implemented in all health care facilities. This includes procedures for the use of preventive ART for health professionals who have been exposed to HIV.
  2. If the appropriate safeguards for protecting physicians or patients against infection are not in place, physicians and National Medical Associations should take action to correct the situation.
  3. Physicians who are infected with HIV should not engage in any activity that creates a risk of transmission of the disease to others. In the context of possible exposure to HIV, the activity in which the physician wishes to engage will be the determining factor. Whether or not an activity is acceptable should be determined by a panel or committee of health care workers with specific expertise in infectious diseases.
  4. In the provision of medical care, if a risk of transmission of an infectious disease from a physician to a patient exists, disclosure of that risk to patients is not enough; patients are entitled to expect that their physicians will not increase their exposure to the risk of contracting an infectious disease.
  5. If no risk exists, disclosure of the physician's medical condition to his or her patients will serve no rational purpose.

Protecting Patient Privacy and Issues Related to Notification

  1. Fear of stigma and discrimination is a driving force behind the spread of HIV/AIDS. The social and economic repercussions of being identified as infected can be devastating and can include violence, rejection by family and community members, loss of housing and loss of employment, to name only a few. Normalizing the presence of HIV/AIDS in society through public education is the only way to reduce discriminatory attitudes and practices. Until that can be universally achieved, or a cure is developed, potentially infected individuals will refuse testing to avoid these consequences. The result of individuals not knowing their HIV status is not only disastrous on a personal level in terms of not receiving treatment, but may also lead to high rates of avoidable transmission of the disease. Fear of unauthorized disclosure of information also provides a disincentive to participate in HIV/AIDS research and generally thwarts the efficacy of prevention programs. Lack of confidence in protection of personal medical information regarding HIV status is a threat to public health globally and a core factor in the continued spread of HIV/AIDS. At the same time, in certain circumstances, the right to privacy must be balanced with the right of partners (sexual and injection drug) of persons with HIV/AIDS to be informed of their potential infection. Failure to inform partners not only violates their rights but also leads to the same health problems of avoidable transmission and delay in treatment.
  2. All standard ethical principles and duties related to confidentiality and protection of patients' health information, as articulated in the WMA Declaration of Lisbon on the Rights of the Patient, apply equally in the context of HIV/AIDS.

In addition, National Medical Associations and physicians should take note of the special circumstances and obligations (outlined below)associated with the treatment of HIV/AIDS patients.

  1. National Medical Associations and physicians must, as a matter of priority, ensure that HIV/AIDS public education, prevention and counselling programs contain explicit information related to protection of patient information as a matter not only of medical ethics but of their human right to privacy.
  2. Special safeguards are required when HIV/AIDS care involves a physically dispersed care team that includes home-based service providers, family members, counsellors, case workers or others who require medical information to provide comprehensive care and assist in adherence to treatment regimens. In addition to implementing protection mechanisms regarding transfer of information, ethics training regarding patient privacy should be given to all team members.
  3. Physicians must make all efforts to convince HIV/AIDS patients to take action to notify all partners (sexual and/or injection drug) about their exposure and potential infection. Physicians must be competent to counsel patients about the options for notifying partners.

These options should include:

  1. notification of the partner(s) by the patient. In this case, the patient should receive counselling regarding the information that must be provided to the partner and strategies for delivering it with sensitivity and in a manner that is easily understood. A timetable for notification should be established and the physician should follow-up with the patient to ensure that notification has occurred.
  2. notification of the partner(s) by a third party. In this case, the third party must make every effort to protect the identity of the patient.
  3. When all strategies to convince the patient to take such action have been exhausted, and if the physician knows the identity of the patient's partner(s), the physician is compelled, either by law or by moral obligation, to take action to notify the partner(s) of their potential infection. Depending on the system in place, the physician will either notify directly the person at risk or report the information to a designated authority responsible for notification.
In cases where a physician must disclose the information regarding exposure, the physician must:

  1. inform the patient of his or her intentions,
  2. to the extent possible, ensure that the identity of the patient is protected,
  3. take the appropriate measures to protect the safety of the patient,especially in the case of a female patient vulnerable to domestic violence.
  4. Regardless of whether it is the patient, the physician or a third party who undertakes notification, the person learning of his or her potential infection should be offered support and assistance in order to access testing and treatment.
  5. National Medical Associations should develop guidelines to assist physicians in decision-making related to notification. These guidelines should help physicians understand the legal requirements and consequences of notification decisions as well as the medical, psychological, social and ethical considerations.
  6. National Medical Associations should work with governments to ensure that physicians who carry out their ethical obligation to notify individuals at risk, and who take precautions to protect the identity of their patient, are afforded adequate legal protection.

Medical Education

  1. National Medical Associations should assist in ensuring that there is training and education of physicians in the most current prevention strategies and medical treatments available for all stages of HIV/AIDS, including prevention and support.
  2. National Medical Associations should insist upon, and assist with when possible, the education of physicians in the relevant psychological, legal,cultural and social dimensions of HIV/AIDS.
  3. National Medical Associations should fully support the efforts of physicians wishing to concentrate their expertise in HIV/AIDS care, even where HIV/AIDS is not recognized as an official specialty or sub-specialty within the medical education system.
  4. The WMA encourages its National Medical Associations to promote the inclusion of designated, comprehensive courses on HIV/AIDS in undergraduate and postgraduate medical education programs, as well as continuing medical education.

14.10.2006

http://www.wma.net/e/policy/a25.htm

Red Cross Fears Complacency in Asia's Fight Against AIDS




08 March 2007


The International Federation of Red Cross and Red Crescent Societies fears that complacency is allowing HIV-AIDS to continue to spread in Asia. IFRC officials say fresh education campaigns are needed for the younger generation. Ron Corben reports from Bangkok, where the Red Cross has just wrapped up a meeting on AIDS.
An AIDS patient lies in his hospital bed in Jakarta, Indonesia (2004 file photo)

Global managers of the International Federation of Red Cross and Red Crescent Societies were told here this week that complacency over HIV-AIDS is a dangerous trend.
The IFRC says Asia has the second highest rate of new HIV-AIDS infections in the world after Africa, with a million people being infected each year.
More than 20 percent of the world's HIV-positive people live in Asia, and the new infection rate in the region is increasing faster than anywhere else.
Mukesh Kapila, the Red Cross-Red Crescent's special representative on HIV and AIDS, says the challenge in Asia is to re-raise awareness of the epidemic among governments and the public.
Kapila said, "This region used to lead the world once in the fight against HIV-AIDS, in the early days. To see the region has been spared the worst of the epidemic - that is good. But we also see a whole generation of people growing up where in a sense got very complacent."
India and China are the two main countries of concern. The United Nations AIDS organization has estimated there are about five million people living with AIDS in South Asia, mostly in India.
The Chinese Health Ministry estimates there are 650,000 Chinese living with AIDS virus, and almost 50 percent of those are people under the age of 29. In the 12 months to October last year, China reported 183,733 new cases - an increase of 30 percent.
In January, China, with help from the International Labor Organization instituted a program to boost AIDS education in the workplace. The U.S. Department of Labor also provided support for the program.
But Kapila says the IFRC sees "no turning point" in the epidemic's spread through the Asia-Pacific region.
"We will see that in countries like India and China, we'll see the numbers increasing dramatically, unfortunately. We'll see it becoming a visible problem in some countries' populations, and some physical regions - we'll see the people dying of AIDS increasing."
The IFRC is now looking to "re-energize" efforts on prevention, especially in the education of young people.

HIV/AIDS prevention tough in a secret gay city



http://www.thejakartapost.com/detailcity.asp?fileid=20070418.D05&irec=4

City News - Wednesday, April 18, 2007

Prodita Sabarini, The Jakarta Post, Jakarta

The grungy movie theater in Senen, East Jakarta, was full on the weekend, dark and hot from the lack of air-conditioning.

Some of the audience wandered between the seats as a Japanese teen movie played on the big screen. Those still seated seemed not to mind.

Two men in the corridor between the seats brushed arms, exchanged glances, and, without saying a word, moved to the corner for anonymous oral sex.

Inside the rundown auditoriums of the Grand Duta theater, such occurrences are regular.

Amidst Indonesia's conservative and religious society, Jakarta has a live but silent gay scene. The Senen area is one of the scene's main hubs.

"This area is like a gay boulevard," said Yakub Gunawan, a HIV/AIDS prevention activist.

The area, from the Mal Atrium Senen shopping mall to the sidewalks outside the theater, is a gathering place for Jakarta's gay men, he said.

He added that there were many other places in the underground gay scene, including upscale clubs and bars in South Jakarta.

Yakub, who is conducting self-funded research on gay awareness of HIV/AIDS, said few of the people he'd spoken to have a good knowledge of the disease, despite most having obtained higher education.

Yakub said that the fear of stigmatization has hampered HIV/AIDS prevention in the gay community. "They refuse to get themselves tested because they fear society's judgment."

"Most of them know they are in a high risk group prone to HIV infection.
However, there is a kind of denial on their part. They don't want to get tested for HIV because if they're HIV positive they would have to face a double stigma of being gay and having HIV,

"Rather than having to tell their families and facing the social stigma of being gay and having HIV, they choose to be oblivious and ignore the problem," Yakub said.

In Indonesia, to be out and gay remains a taboo. Gay community members are straightforward about their sexual orientation among themselves. However, facing the social pressure of Indonesia's heterosexist society, they hide their sexual orientation when returning to the mainstream. Most significantly, they also hide their sexual orientation from their families.

Yakub said most of the middle-aged men inside the movie theater lead double lives.

"Most of them hide their sexual orientation from their wives and children," he said.

He said he knew of a couple that had been together for 15 years, who both had wives and children of their own. "Their relationship is on-again-off-again, because one or the other of them always cheats with another guy. But it's never because of a woman," he said.

"Deni", in his 30s, said he faced family pressure to get married. He said he was tired of living as a gay man.

The youngest of seven children from a mixed Batak and Padang family, Deni said he was the only child in the family still single, and was frequently asked about his marriage plans. "I'm living with a partner, but it's going nowhere," he said.

Deni said that, despite his sexual orientation, he wanted to marry a woman and raise a family. "Of course I can like a woman, I just have to get used to it first."

Yakub said the phenomenon of gay sex within heterosexual marriages can increase the risk of HIV infection for wives, just as the wives of injecting drug users can be infected by their husbands.

Some 14 of Yakub's 25 research respondents agreed to be tested for HIV. Four of them tested positive.

"I believe that number is just the tip of the iceberg", he said.

"April", a hairdresser, who participated in Yakub's research, said he lacked knowledge about safe sex and how to protect himself from HIV infection. His test result showed he was HIV positive.

"I didn't know any better," he said.

April had an active sex life, having unprotected sex with up to 20 men in one year. "If I had known (about HIV prevention) I would have been more cautious about protecting myself," he said.

Yakub said gathering places such as the Grand Duta theater were good opportunities to reach out to gay men about HIV/AIDS prevention.

"If people know that Grand is a gay place, some members of society might want to close it down. But that wouldn't make gay people disappear, because they are part of (this) society. (Closing these places down) would rather make it more difficult to identify them, making HIV/AIDS prevention harder among this group," he said.

WHO and UNAIDS issue new guidance on HIV testing and counselling in Asia and The Pacific



http://www.who.int/hiv/who_pitc_guidelines.pdf
New recommendations aim for wider knowledge of HIV status and greatly
increased access to HIV treatment and prevention

30 MAY 2007 | LONDON -- WHO and UNAIDS today issued new guidance on
informed, voluntary HIV testing and counselling in the world's health
facilities, with a view to significantly increasing access to needed
HIV treatment, care, support and prevention services. The new
guidance focuses on provider-initiated HIV testing and counselling
(recommended by health care providers in health facilities).

Today, approximately 80% of people living with HIV in low- and middle-
income countries do not know that they are HIV-positive. Recent
surveys in sub-Saharan Africa showed on average just 12% of men and
10% of women have been tested for HIV and received their test results.

Increased access to HIV testing and counselling is essential to
promoting earlier diagnosis of HIV infection, which in turn can
maximize the potential benefits of life-extending treatment and care,
and allow people with HIV to receive information and tools to prevent
HIV transmission to others.

"Scaling up access to HIV testing and counselling is both a public
health and a human rights imperative," said WHO HIV/AIDS Director Dr
Kevin De Cock. "We hope that the new guidance will provide an impetus
to countries to greatly increase availability of HIV testing services
in health care settings, through realistic approaches that both
improve access to services and, at the same time, protect the rights
of individuals. Without a major increase in HIV testing and
counselling in health facilities, universal access to HIV prevention,
treatment and care will remain just a noble goal."

Additional approaches needed to expand access

Until recently, the primary model for providing HIV testing and
counselling has been client-initiated HIV testing and counselling -
also known as voluntary counselling and testing (VCT) - in which
individuals must actively seek an HIV test at a health or community-
based facility. But uptake of client-initiated HIV testing and
counselling has been limited by low coverage of services, fear of
stigma and discrimination, and the perception by many people - even
in high prevalence areas - that they are not at risk.

Current evidence also suggests many opportunities to diagnose HIV in
clinical settings are being missed, even in places with serious HIV
epidemics. While, therefore, expanded access to client-initiated HIV
testing and counselling is still necessary, other approaches are also
required if coverage of HIV testing and counselling is to increase
and, ultimately, universal access to HIV prevention, treatment, care
and support is to be achieved.

The new WHO/UNAIDS guidance was prepared in light of increasing
evidence that provider-initiated testing and counselling can increase
uptake of HIV testing, improve access to health services for people
living with HIV, and may create new opportunities for HIV prevention.

Provider-initiated HIV testing and counselling involves the health
care provider specifically recommending an HIV test to patients
attending health facilities. In these circumstances, once specific
pre-test information has been provided, the HIV test would ordinarily
be performed unless the patient declines.

Provider-initiated HIV testing and counselling has already been
implemented in a range of clinical settings in several low- and
middle-income countries, including Botswana, Kenya, Malawi, Uganda
and Zambia, as well as in pre-natal settings in parts of Canada,
Thailand, the United Kingdom, and the United States


"If we are going to get ahead of this epidemic, rapidly scaled up HIV
treatment and prevention efforts are critical - and increased uptake
of HIV testing will be fundamental to making this a reality," said Dr
Paul De Lay, Director of Monitoring and Evaluation, UNAIDS. "At the
same time, and in all cases of HIV testing and counselling, the 3 Cs -
that is consent, confidentiality and counselling - must be
respected," he added.

Guidance tailored to different types of epidemics and health
facilities

The new WHO/UNAIDS guidance advises that health care providers
globally should recommend HIV testing and counselling to all patients
who present with conditions that might suggest underlying HIV disease.

Additional guidance is tailored to local circumstances. In
generalized HIV epidemics1, HIV testing and counselling should be
recommended to all patients attending all health facilities, whether
or not the patient has symptoms of HIV disease and regardless of the
patient's reason for attending the health facility. In concentrated2
and low-level3 HIV epidemics, depending on the epidemiological and
social context, countries should consider recommending HIV testing
and counselling to all patients in selected health facilities (e.g.
antenatal, tuberculosis, sexual health, and health services for most-
at-risk populations). The guidance also includes special
considerations for HIV testing and counselling for adolescents and
children.

WHO and UNAIDS recognize that resource and other constraints may
prevent immediate implementation of the guidance. The document
therefore provides advice about how to prioritize implementation in
different types of health facilities.

The new guidance builds on previous policy positions of WHO and
UNAIDS and responds to a growing demand from countries for more
detailed policy and operational advice in this area. Its
recommendations were developed following a review of available
evidence and a broad consultative process with experts and
implementers, including submissions received from over 150
organizations and individuals.

Other key recommendations

Other key WHO/UNAIDS recommendations for provider-initiated HIV
testing and counselling in health facilities include:

  • All HIV testing must be voluntary, confidential, and undertaken with the patient's consent.
  • Patients have the right to decline the test. They should not be tested for HIV against their will, without their knowledge,without adequate information or without receiving their test results.
  • Pre-test information and post-test counselling remain integral components of the HIV testing process.
  • Patients should receive support to avoid potential negative consequences of knowing and disclosing their HIV status, such as discrimination or violence.
  • Testing must be linked to appropriate HIV prevention, treatment, care and support services.
  • Decisions about HIV testing in health facilities should always be guided by what is in the best interests of the individual patient.
  • Provider-initiated HIV testing and counselling is not, and should not be construed as, an endorsement of coercive or mandatory HIV testing.
  • Implementation of provider-initiated HIV testing and counselling should be undertaken in consultation with key stakeholders, including civil society groups, acknowledging that what works and is ethical will inevitably differ across countries.
  • When implementing provider-initiated HIIV testing and counselling, equal efforts must be made to ensure that a supportive social, policy and legal framework is in place to maximize positive outcomes and minimize potential harms to patients.
  • A system that monitors and evaluates the implementation and scale-up of provider-initiated testing and counselling should be developed and implemented concurrently.


As countries work towards universal access to HIV prevention,
treatment, care and support, the new guidance on provider-initiated
HIV testing and counselling offers an important opportunity to
introduce new approaches and improve the standards of HIV testing and
counselling in both public and private health facilities. Together
with their partners, WHO and UNAIDS will continue to help countries
expand access to the full range of HIV testing and counselling
services, as well as to other needed health sector interventions
against HIV/AIDS.

  1. HIV is firmly established in the general population. Numerical proxy: HIV prevalence consistently over 1% in pregnant women.
  2. HIV has spread rapidly in a defined sub-population, but is not well-established in the general population. Numerical proxy: HIV prevalence is consistently over 5% in at least one defined sub-population, but is below 1% in pregnant women in urban areas.
  3. HIV has never spread to significant levels in any sub-population. Numerical proxy: HIV has not consistently exceeded 5% in any sub-population.


[WHO (2007) GUIDANCE ON PROVIDER-INITIATED HIV TESTING AND COUNSELLING IN HEALTH FACILITIES is available on the following url http://www.who.int/hiv/who_pitc_guidelines.pdf

Circumcision appears to reduce AIDS risk from sex in men


http://www.iht.com/articles/2006/12/14/news/aids.php

By Donald G. McNeil Jr.

Thursday, December 14, 2006

Circumcision appears to reduce a man's risk of contracting AIDS from heterosexual sex by half, according to U.S. government health officials.

Because circumcision was working so well that continuing clinical trials would be unethical, the officials said Wednesday that they had stopped two of the trials in Africa.

AIDS experts immediately hailed the finding, and the directors of the U.S. and international funds for fighting the disease said they would now consider paying for circumcisions.

"This is very exciting news," said Daniel Halperin, an HIV specialist at the Harvard Center for Population and Development, who has argued in scientific journals for years that circumcision slows the spread of AIDS in the parts of Africa where it is common.

In an interview from Zimbabwe, he added, "I have no doubt that as word of this gets around, millions of African men will want to get circumcised, and that will save many lives."

Uncircumcised men are thought to be more susceptible because the underside of the foreskin is rich in Langerhans cells, sentinel cells of the immune system, which attach easily to the human immunodeficiency virus, which causes AIDS. The foreskin also often suffers small tears during intercourse.

But experts also cautioned that circumcision is no cure-all. It only lessens the chances that a man will catch the virus; it is expensive compared with condoms, abstinence or other methods, and the surgery has serious risks if performed by folk healers using dirty blades, as often happens in rural Africa.

Circumcision is "not a magic bullet, but a potentially important intervention," said Kevin De Cock, director of HIV/AIDS for the World Health Organization.

Sex education messages for young men need to make it clear that "this does not mean that you have an absolute protection," said Anthony Fauci, an AIDS researcher and director of the National Institute of Allergy and Infectious Diseases. Circumcision should be used with other prevention methods, he said, and it does nothing to prevent spread by anal sex or drug injection, ways in which the virus commonly spreads in the United States, for example.

The two trials, conducted by researchers from universities in the United States, Canada, Uganda and Kenya, involved nearly 3,000 heterosexual men in Kisumu, Kenya, and nearly 5,000 in Rakai, Uganda. None were infected with HIV; they were divided into circumcised and uncircumcised groups. They were given safe-sex advice, although many presumably did not take it, and tested again regularly.

The trials started in 2001 and reached their target enrollments in September 2005. The trials were to have continued until mid-2007 but were stopped this week by the National Institutes of Health's Data and Safety and Monitoring Board. The halt came after data showed that the Kenyan men had a 53 percent reduction in new HIV infection.

Twenty-two of the 1,393 circumcised men in the study caught the disease, compared with 47 of the 1,391 uncircumcised men. In Uganda, the reduction was 48 percent. Those results echo the finding of a trial completed last year in Orange Farm, a township in South Africa, financed by the French government, which demonstrated a reduction of 60 percent among circumcised men.

The two largest agencies dedicated to fighting AIDS said they would now be willing to pay for circumcisions, which they had not before because there was too little evidence that it worked.

Richard Feachem, executive director of the Global Fund to Fight AIDS, Tuberculosis and Malaria, which has almost $5 billion in pledges, said in a television interview that if a country submitted plans to conduct safe, sterile circumcisions, "I think it's very likely that our technical panel would approve it."

Mark Dybul, executive director of the President's Emergency Plan for AIDS Relief, a $15 billion fund established by President George W. Bush, said in a statement that his agency "will support implementation of safe medical male circumcision for HIV/AIDS prevention" if world health agencies recommended it.

He also warned that it was only one new weapon in the fight, adding, "Prevention efforts must reinforce the ABC approach — abstain, be faithful, and correct and consistent use of condoms."

Researchers have long noted that parts of Africa where circumcision is common — particularly the Muslim countries of West Africa — have much lower AIDS rates, while those in southern Africa, where circumcision is rare, have the highest.

But drawing conclusions was always confounded by other regional factors, like strict Shariah law in some Muslim areas, rape and genocide in East Africa, polygamy, rites that require widows to have sex with a relative, or patronage of prostitutes by miners and migrant workers in the south.

Outside Muslim regions, circumcision is spotty. In South Africa, for example, the Xhosa people circumcise teenage boys, while Zulus do not. AIDS is common in both tribes.

HIV Serostatus Should Not Be a Criterion for or Against Surgery


http://www.medscape.com/viewarticle/549771

By Megan Rauscher

NEW YORK (Reuters Health) Dec 21 - HIV serostatus should not be a criterion used to decide for or against surgery, researchers conclude based on a retrospective study of 332 HIV-infected and HIV-noninfected pairs of patients. However, optimizing the CD4 count and getting the viral load as low as possible before surgery is best, they note.

In their analyses, HIV-infected patients relative to their HIV-negative counterparts had the same overall rates of surgical complications, including wound infection, need for repeat surgery, general postoperative infection, and wound dehiscence, Dr. Michael A. Horberg from Kaiser Permanente Medical Center in Oakland, California and colleagues report in the December Archives of Surgery.

"Further, we found no greater length of hospital stay for the HIV-infected patients, nor did they have more frequent follow-up visits to the surgeon, meaning they were getting the same amount of care as their HIV-negative counterparts," Dr. Horberg told Reuters Health.

The HIV-infected patients did have a statistically greater number of pneumonias postoperatively than the HIV-negative patients, but the number of cases was small, Dr. Horberg said. There were 8 cases of pneumonia among the HIV-infected group and 1 among the HIV-negative group.

"At 12 months out, there were more deaths among the HIV-infected patients compared to the HIV-negative patients (10 deaths vs. 2)," Dr. Horberg noted, "but looking at the causes of death, we really did not think these deaths were surgically related."

"Interestingly," he said, "the HIV-infected patients who had cardiothoracic surgery (19 cases) seemed to do better than their HIV-negative counterparts."

Having a high viral load (> 30,000 copies/mL) predicted a higher complication rate, as did having a low CD4 T-cell count ( <>

The significance of this study, the authors note, lies in its size - it is believed to be the largest analysis of surgical outcomes for HIV-infected patients in the modern HAART era -- as well as the varieties of common operations represented, and the matching of HIV-positive with HIV-negative patients.

Arch Surg 2006;141:1238-1245.

Saturday, 16 June 2007

World AIDS Day message



http://www.who.int/mediacentre/news/statements/2006/s17/en/index.html

Dr Anders Nordström, Acting Director-General


1 December 2006

The HIV/AIDS epidemic continues to grow. Some 40 million people, their families, and their communities, are now living with HIV. Effectively tackling this epidemic remains one of the world's most pressing public health challenges.

In August this year, at the XVI International AIDS Conference, 30 000 of us came together in Toronto in reply to the Conference's call to action. That action, we agreed, must reflect a balanced mix of prevention, treatment and care. This year's World AIDS Day theme "Accountability" reminds us again of our responsibility for making the right choices.

In Toronto, I spoke on the three areas in which we had to take action: the three "Ms" of Money, Medicines and a Motivated workforce.

Money: We have made some important progress and continue to do so. For example, just over half of the latest round of grants from the Global Fund - which totalled US$846 million - will go to fight HIV/AIDS. Continued commitment is needed and resources must be used effectively. Accountability is an important theme for those who want to see the best possible results in terms of human lives.

Medicines: Our goal remains to scale up international efforts to provide universal access to prevention, treatment, care and support services.The ten-fold increase in people on treatment in sub-Saharan Africa in recent years shows that we can do it. Sub-Saharan Africa also illustrates what still has to be done: it represents 70% of the global unmet need for treatment.

We have a very long way to go still in the provision of medicines to those who need them. To be able to do that, we must also know who needs treatment and care.

The latest AIDS epidemic update from WHO and the UNAIDS Secretariat, released on 21 November, gives us the most accurate picture of the epidemic to date. HIV surveillance remains weak in almost all regions, particularly among marginalized groups. Those at highest risk—men who have sex with men, sex workers, and injecting drug users—are not reliably reached through HIV prevention and treatment strategies.

At the Toronto Conference there was a powerful drive to address the needs of those who bear the greatest burden of the AIDS epidemic - women and girls. Some 40% of new HIV infections now occur among young people aged between 15 to 24 years. The most striking increases in the number of people living with HIV have occurred in East Asia, Eastern Europe and Central Asia.

Those most at risk of exposure to HIV do not always know how to protect themselves and often do not have access to the means to do so, such as condoms, clean needles and syringes, and treatment for sexually transmitted infections. Levels of knowledge of safer sex and HIV remain low in many countries, as well as perceptions of personal risk. Even in countries where the epidemic has a very high impact, such as Swaziland and South Africa, a large proportion of the population do not believe they are at risk. Where prevention efforts decline, HIV infects more people.

Counselling and testing are essential so that people who are infected can know their status, seek care, and using their increased knowledge, change their behaviours to prevent transmission of the virus to others. Those who are tested can also use knowledge of their status to protect themselves.

A Motivated health workforce: Motivated and skilled health workers who can provide essential services are the crucial missing link in many countries. WHO's "Treat, Train Retain" plan for a healthy and well supported healthcare workforce is being developed now in 15 countries.

Prevention works but has to be focused on the needs of those most likely to be exposed to HIV, and it must be sustained. There are success stories. In 8 out of 11 of some of the world's most affected countries, HIV prevalence in the age group 15 to 24 years has declined in the past five years. We must seize on these successes and see that they are repeated.

We know that comprehensive harm reduction programmes reduce risky drug injecting practice and result in declines in HIV infection rates. Effective responses are being implemented in many countries, ranging from Brazil and China to the Islamic Republic of Iran and Indonesia. These experiences provide good models for other countries.

Another key element in the epidemic - Tuberculosis - has recently drawn increased attention with the development of an extremely drug resistant form that signals the urgent need for TB control. TB causes up to half of all deaths in people living with HIV.

The AIDS epidemic provides us with clear evidence that even some of the most complex health and development problems can be successfully addressed. To see this positive pattern repeated everywhere will take greater political will and more resources.

Our ability to be responsive to changes in the epidemic is a central factor if we are to succeed. We have to be constantly alert to shifts in the epidemic dynamic and country contexts, aware of which approaches are successful, and flexible enough to adapt our responses accordingly. We do not just need "more". We need to commit to clear sightedness about what is working and what is not - and quickly apply that knowledge.

For example, recognizing the critical role that vulnerable and marginalized populations play in the epidemic, we need to invest in models of service delivery that reach these groups, ensure equitable and quality services, and are able to provide sustainable support to the most affected communities.

We are now more than 25 years into this epidemic. People living with HIV and their communities urgently need to see tangible results. We are at a critical juncture. Just last week, Secretary-General Kofi Annan inaugurated the new joint UNAIDS/WHO building in Geneva. It is a building which now houses the HIV, TB and Malaria staff of WHO, side by side with the UNAIDS team. Nothing more clearly symbolises our determination to work as a team. It is a commitment to collaboration, and with that comes our commitment also to accountability: to all those currently living with HIV, and to all those whose lives must be protected from it.

HIV Epidemic Grows to 39.5 Million Infected

http://health.aol.com/news/story/_a/hiv-epidemic-grows-to-395-million/n20061121053609990008?cid=474

By ELIANE ENGELER

AP

GENEVA (Nov. 21) - The global HIV epidemic is growing, leaving an estimated 39.5 million people worldwide infected with the deadly virus, the United Nations said Tuesday.

AIDS has claimed 2.9 million lives this year and another 4.3 million people became infected with HIV, according to the U.N.'s AIDS epidemic update report, published on Tuesday. Spread of the disease was most noticeable in East Asia, Eastern Europe and Central Asia.

AIDS has killed more than 25 million people since the first case was reported in 1981, making it one of the most destructive illnesses in history.

"In a short quarter of a century AIDS has drastically changed our world," U.N. Secretary-General Kofi Annan said at a staff meeting Monday in Geneva. "AIDS, tuberculosis and malaria make up the deadliest triad the world has known."

But he said improvement in treatment, more resources and higher political commitment over the past 10 years gave rise to optimism.

The joint report by UNAIDS and the World Health Organization acknowledged that access to HIV/AIDS treatment has made a great leap forward in recent years, enabling many infected people to live longer. But it said much remained to be done, especially in prevention.

Sub-Saharan Africa - with 63 percent or 24.7 million of the world's infected people - bears the highest burden, but in East Asia, Eastern Europe and Central Asia there are 21 percent more people living with HIV than two years ago.

The virus spread fastest in Eastern Europe and Central Asia, with a nearly 70 percent increase in new infections over the past two years. In South and Southeast Asia, the number of new infections has grown by 15 percent since 2004, while it rose by 12 percent in North Africa and the Middle East. In Latin America, the Caribbean and North America it remained roughly stable.

All regions of the world have had an increase in the number of people living with the deadly virus over the past two years, the report said. In some countries this was due to better access to medicine keeping people alive longer.

Never before have so many women been infected with HIV. There are 17.7 million women worldwide carrying the virus, an increase of more than 1 million compared with two years earlier. The proportion of women among the infected is particularly striking in sub-Saharan Africa where they account for 59 percent of the people with HIV/AIDS.

The report doesn't break down the estimates country by country, but it said the United States - for which figures were available for 2005 only - had 1.2 million people living with HIV last year. The U.S. therefore ranks among the top 10 countries in terms of infected people.

Unprotected sex in prostitution and between men, as well as unsafe drug injecting represent the highest risks for HIV infection and the main reasons for the spread of the disease in Asia, Eastern Europe and Latin America, it said.

After sub-Saharan Africa, Asia is the second most infected region. Almost 8 million of the world's people with HIV/AIDS live in South and South East Asia. The report said there is increasing evidence for HIV outbreaks among men who have sex with each other in Cambodia, China, India, Nepal, Pakistan, Vietnam and Thailand, but it said few of these countries' AIDS programs really address the problem of sex between males.

In North America, an estimated 1.4 million people are infected, which represents a steady increase over the past few years mainly due to the life-prolonging impact of antiretrovirals.

In the United States, people from racial and ethnic minorities are more affected by the epidemic, with half of the AIDS diagnoses between 2001 and 2004 among African Americans and 20 percent among Hispanics.

But infected people in the U.S. have been benefiting from more effective treatment over the past few years, leading to a 21-percent increase of infected people surviving two years or longer since the early 1990s.

Copyright 2006 The Associated Press. The information contained in the AP news report may not be published, broadcast, rewritten or otherwise distributed without the prior written authority of The Associated Press. All active hyperlinks have been inserted by AOL.

11/21/06 05:32 EST

Scientists get snapshot of AIDS defense mechanism



By Maggie Fox, Health and Science EditorThu Nov 2, 10:23 PM

Scientists trying to figure out why a few people resist the ravages of AIDS say they have captured a snapshot of an immune system structure that could help them design a drug to boost the body's defenses against the virus.

Having an image of the enzyme, called A3G, could help researchers design a drug to mimic its effects and perhaps provide the first medicine to boost the ability to fight AIDS, the team at the University of Rochester Medical Center in New York said.

A small percentage of people infected with HIV never become ill. They are called long-term non-progressors, or "elite" patients.

Some studies have suggested that these elite patients have extra copies of A3G, which disables HIV by making it mutate to death.

"We all know that HIV gets away from therapy by creating a lot of mutations in itself," said Harold Smith, a professor of biochemistry and biophysics who helped lead the study.

"This enzyme has the ability to push mutations in HIV to the point where the viruses' own genome fails. If we protect this enzyme, we have the ability to push HIV into failure," Smith said in a telephone interview.

HIV fights back against A3G with a gene called vif. In most cases, HIV overwhelms A3G as it attacks the immune system.

"It is like cell wars going on. It is the number of vifs and A3Gs that you have that makes a difference," Smith said.

Writing in this week's issue of the Journal of Biological Chemistry, Smith and colleagues said they had taken a rough image of the A3G structure. They could not quite achieve X-ray
crystallography, which images structures on an atomic level.

"This is a nanoparticle," Smith said "It is resolution at a billionth of a meter."

Knowing what the structure looks like can help in a process known as rational drug design, in which scientists build a new drug molecule by molecule, to precisely match a target like a key fitting into a lock.

"Here is a host defense factor which the virus tries to eliminate and if we had some way of shielding it, we could help white blood cells defend themselves," Smith said.

The structure defends against other, similar viruses, including hepatitis B, Smith said.

"We believe this work will lead to the development of new treatments that enable patients to better harness their own natural defense mechanisms."

The AIDS virus infects 40 million people globally and has killed 25 million. Although there are about 20 different drugs on the market that can help control the virus, there is no cure and no vaccine.

Copyright © 2006 Reuters Limited.

Lift stigma from HIV screening

Posted 10/8/2006 8:04

For most of the 1980s, a diagnosis of AIDS was a virtual death sentence. People suspected of having the incurable disease were shunned, fired from jobs or driven from homes. Many avoided getting tested for fear that their status would be revealed.

OPPOSING VIEW: Don't remove safeguards

The progress since then has been remarkable. New medications keep the HIV virus in check so that patients who are diagnosed early can extend their lives by 25 years, according to a Harvard Medical School study. Public attitudes have softened.

But that progress has exposed a new problem — and opportunity. Far too often, the disease isn't discovered as quickly as it could be, endangering those people as well as others they might infect. As many as 1.2 million Americans are HIV-positive, and an additional 40,000 are infected each year.

Making HIV screening as routine as tests for high blood pressure would address the problem. New guidelines from the federal Centers for Disease Control and Prevention urge providers to offer regular, routine — but voluntary — testing for everyone 13 to 64.

The CDC also wants states to reconsider laws that deter testing. Some 31 states require specific informed consent, and 23 demand extensive pretest counseling. Those outdated laws were written for a time when little was known about AIDS.

Some civil liberties and AIDS advocacy groups worry that testing could become mandatory and compromise patient confidentiality, but that is a concern with all medical records and can be controlled.

The benefits of wider testing far outweigh the risks.

As many as 300,000 people with HIV don't know they have it. Their own health is in jeopardy, and they unwittingly transmit the disease to others. People who don't know they carry HIV account for up to 70% of new infections. When they do become aware of their status, they take steps to avoid infecting others — a two-thirds reduction in risky sexual behavior.

Further, the screening of all pregnant women, which started in 1995, decreased the number of children who contracted AIDS via their mothers from a peak of 945 in 1992 to 48 in 2004.

Because HIV can be diagnosed before symptoms develop, finding more infections gets patients into treatment faster, slows the spread of AIDS and saves lives. The widespread screening that so dramatically lowered the AIDS rate in babies can do the same for adults.

Membuat Pekerja Sadar akan HIV/AIDS

http://www.suarapembaruan.com/News/2006/10/31/Urban/urb01.

SUARA PEMBARUAN DAILY

Salmon Sinaga, manajer sumber daya manusia PT Filamendo Sakti tidak hanya piawai melaksanakan tugas-tugas yang berkaitan dengan manajemen karyawan. Ia juga piawai menyampaikan informasi seputar HIV/AIDS kepada karyawan yang jumlahnya 856 orang, mulai dari operator sampai tingkat manajer.

Salmon, adalah satu dari sembilan mentor yang dilatih lembaga swadaya masyarakat Yayasan Kusuma Buana (YKB), yang berkecimpung di sektor kesehatan. Para mentor itu dilatih untuk dapat menyosialisasikan penanggulangan HIV/AIDS di tempat kerja.

Sejak tahun 2005, ujarnya, ia dan delapan temannya menginformasikan HIV/AIDS kepada karyawan. Sosialisasi dilaksanakan melalui pelatihan selama dua hari di kelas dari pukul 15.00 sampai 17.00.

Satu kelas terdiri atas 30 karyawan. Setelah pelatihan, Salmon dan mentor lainnya mengevaluasi pengetahuan karyawan tentang HIV/AIDS dengan tes pilihan berganda, dan menuliskan informasi HIV/AIDS yang diketahuinya. Bila tidak lulus, karyawan akan tes ulang.

Bila karyawan tidak hadir selama pelatihan, diberi surat peringatan, kecuali ada surat keterangan sakit dari dokter. Tidak itu saja, manajer dari karyawan yang tidak hadir pun diberi surat peringatan.

Begitulah sekilas gambaran sosialisasi HIV/AIDS di PT Filamendo Sakti, perusahaan yang bergerak di bidang benang ban. Tahun ini, perusahaan tersebut menerima penghargaan AIDS Award untuk kategori emas yang diserahkan Menteri Koordinator Bidang Kesejahteraan Rakyat (Menko Kesra) Aburizal Bakrie, yang sekaligus menjabat Ketua Komisi Penanggulangan AIDS (KPA) Nasional beberapa waktu lalu.

Ada 19 perusahaan yang menerima "AIDS Award" untuk kriteria emas (lima perusahaan), perak (sepuluh perusahaan) dan perunggu (empat perusahaan).

"Setelah dilatih, karyawan wajib menceritakan HIV/AIDS kepada keluarganya, kemudian ke lingkungan. Selain pelatihan, kami juga membuat pin, brosur, dan pamflet tentang HIV/AIDS. Semua kegiatan yang terkait dengan HIV kami laporkan ke induk perusahaan PT Gajah Tunggal Tbk," Salmon menjelaskan.

Lalu, bagaimana bila ada karyawan yang terinfeksi HIV? Menurutnya, perusahaan memiliki kebijakan tidak membedakan karyawan yang terinfeksi HIV. Mereka tetap bekerja dan mendapatkan asuransi kesehatan. Ia menegaskan, tidak ada diskriminasi terhadap pengidap HIV.

Usia Produktif

Dampak epidemi AIDS terhadap dunia usaha tidak bisa dihindarkan. Fakta menunjukkan, sebagian besar kasus infeksi HIV terjadi pada kelompok usia produktif. Data International Labor Organization (ILO), dari 40 juta orang yang terinfeksi HIV di seluruh dunia, 25 juta di antaranya adalah pekerja.

Di Indonesia, sembilan dari sepuluh orang yang terinfeksi berada dalam kelompok usia kerja produkif, yang berusia 19 sampai 39 tahun. Kondisi itu juga diperburuk dengan kenyataan sejumlah pekerja yang terpisah jauh dari keluarga dalam waktu yang lama mencari hiburan dengan berhubungan seks berganti-ganti pasangan tanpa kondom. Data Departeman Kesehatan tahun 2002 memperlihatkan, sekitar tujuh juta sampai sepuluh juta laki-laki yang menjadi pelanggan seks komersial. Sebagian besar adalah pekerja, dan kurang dari sepuluh persen yang konsisten menggunakan kondom.

Kondisi semacam itu, ujar Direktur Pelayanan Kesehatan YKB dr Adi Sasongko MA, yang membuat kasus AIDS terus meningkat.

"Belum banyak perusahaan yang menyosialisasikan HIV/AIDS di tempat kerja. Masih banyak anggapan tidak benar tentang HIV/AIDS. Misalnya dianggap mudah menular, penyakit yang tidak benar, penularan di luar tempat kerja, sehingga karyawan yang terinfeksi HIV dikucilkan, dipecat dan biaya kesehatannya tidak ditanggung," kata Adi.

Menurutnya, perusahaan akan memperoleh manfaat bila melaksanakan penanggulangan HIV/AIDS di tempat kerja. Karena, para pekerja adalah orang-orang yang berusia produktif sehingga masih memiliki waktu yang panjang untuk bisa berkarya. Terlebih lagi, penularan HIV tidak segampang penularan penyakit lain seperti tuberkulosis (TBC). HIV menular melalui hubungan seks yang tidak aman, dan pemakaian jarum suntik tidak steril, khususnya pada pemakai narkoba suntik.








Sejumlah warga negara Papua Nugini melintasi papan peringatan terhadap bahaya penyakit AIDS di Kantor Imigrasi Papua Nugini di Perbatasan RI-Papua Nugini, Skouw, Papua, Minggu (15/01/06). Tingginya tingkat penyebaran AIDS di wilayah Papua menyebabkan Pemprov Papua dan Pemerintah Papua Nugini melakukan kampanye bersama pencegahan AIDS. [Pembaruan/Jurnasyanto Sukarno]

Depresi
Adi menggambarkan kerugian perusahaan bila memecat dan mendiskriminasi karyawan yang terinfeksi HIV. Perusahaan harus mengganti karyawan, yang belum tentu memiliki keterampilan seperti karyawan lama. Untuk itu, perusahaan harus merekrut dan melatih karyawan baru, yang semuanya memerlukan waktu dan biaya.

Diskriminasi yang dilakukan orang sekitar, katanya, justru membuat pengidap HIV depresi dan penyakit itu yang bisa membuat seorang pengidap HIV meninggal. Jadi bukan karena AIDS.

Dalam sejarahnya, ujar dosen Fakultas Kesehatan Masyarakat Universitas Indonesia itu justru kebijakan pemerintah yang bersifat diskriminasi. Ada peraturan Departemen Tenaga Kerja yang menyebutkan, karyawan yang terinfeksi HIV, mengidap penyakit menular seksual, pemakai narkoba diperkecualikan dari pelayanan kesehatan di tempat kerja. Inilah yang melatarbelakangi asuransi kesehatan tidak menanggung biaya kesehatan karyawan dengan penyakit-penyakit tersebut.

"Ironisnya banyak pihak yang menjadi hakim, dan menganggap dirinya tidak berdosa sehingga mengucilkan mereka. Sementara, dunia global menolak hal semacam ini," katanya.

Adi menambahkan, dengan tujuan pencegahan dan menghilangkan diskriminasi terhadap pekerja yang terinfeksi HIV, kriteria penghargaan AIDS Award pun terdiri dari penyuluhan, pelatihan, penyebaran informasi HIV/AIDS di tempat kerja. Upaya itu didukung oleh kebijakan perusahaan yang nondiskriminasi. Kriteria lain adalah, perusahaan mengalokasi waktu, dana, dan memberi kesempatan kepada karyawan untuk mengikuti pelatihan. Lebih baik lagi, ujarnya, bila ada upaya menjangkau masyarakat sekitar lingkungan kerja. [Pembaruan/Nancy Nainggolan]